Page results
-
We provide a comprehensive service from early diagnosis to advanced treatments for severe COPD. We have a strong multidisciplinary team (MDT) including doctors, specialist nurses, physiotherapists, physiologists and psychologists, which enables us to provide holistic, personalised care to each of our patients.
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
We offer an expert service for complex pulmonary embolic disease (PED) and follow up for all cases diagnosed with this condition at UCLH.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
We provide a specialist service for the assessment and treatment of sarcoidosis as part of the interstitial lung disease (ILD) service at UCLH. We provide holistic multidisciplinary care, with a weekly consultant-led outpatient clinic and clinical nurse specialist support.
-
This page is for patients who are receiving radiotherapy to the bladder.
-
The London Sarcoma Service is one of the largest sarcoma services in Europe with an international reputation for providing the highest quality of care to patients with sarcoma.
-
UCLH is a specialist centre for the treatment of urological cancers.
-
This clinic is for asymptomatic travellers (individuals with no current symptoms) who have travelled to a tropical destination and are worried about certain infections.
-
This page, written by the Physiotherapy Services at the Royal London Hospital for Integrated Medicine, is intended for patients (or their family or carers) who have been referred to the clinic.
File results
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments